Close Menu

NEW YORK ─ Hologic on Monday said it has priced its previously announced $950 million private offering of 3.250 percent senior notes due in 2029 at an issue price of $1,000 per $1,000.

Marlborough, Massachusetts-based Hologic intends to use the proceeds of the offering and available cash to refinance its existing 4.375 percent senior unsecured notes due 2025 and will use current cash to pay transaction-related premiums, fees, and expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.